Cimetidine in malignant melanoma
- PMID: 2800583
Cimetidine in malignant melanoma
Similar articles
-
Cimetidine reduces impairment of cellular immunity after transcatheter arterial embolization in patients with hepatocellular carcinoma.Hepatogastroenterology. 2003 Mar-Apr;50(50):460-2. Hepatogastroenterology. 2003. PMID: 12749247 Clinical Trial.
-
Immunomodulating activities on cellular cytotoxicity and the blast transformation of human lymphocytes by 10-[n-(phthalimido)alkyl-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10 H-phenothiazin-10-yl)alkyl-1-ureas.Anticancer Res. 1996 May-Jun;16(3A):1247-50. Anticancer Res. 1996. PMID: 8702245
-
[Effect of different immunomodulators on the subpopulations of immunocompetent cells. The immunomodulating therapy of respiratory diseases].Ter Arkh. 1985;57(1):70-5. Ter Arkh. 1985. PMID: 3872483 Russian.
-
[Natural immunostimulants].Antibiotiki. 1983 Sep;28(9):702-16. Antibiotiki. 1983. PMID: 6357066 Review. Russian. No abstract available.
-
Does cimetidine improve prospects for cancer patients?. A reappraisal of the evidence to date.Digestion. 1999 Sep-Oct;60(5):415-21. doi: 10.1159/000007686. Digestion. 1999. PMID: 10473965 Review.
MeSH terms
Substances
LinkOut - more resources
Medical